Aminoanthraquinones as novel ligands at the polyamine binding site on the N-methyl-D-aspartate receptor complex

Aimee K. Bence, Dennis T. Rogers, David R. Worthen, May Fu, John M. Littleton, Peter A. Crooks

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

As part of a drug discovery program using high-throughput radioligand-binding assays, aminoanthraquinones were identified as potential modulators of N-methyl-D-aspartate (NMDA) receptor function. Aminoanthraquinones may represent a novel class of polyamine binding site ligands with a unique pharmacophore and may facilitate the rational design of novel NMDA-receptor modulators. (C) 2000 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)2621-2623
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Volume10
Issue number23
DOIs
StatePublished - Dec 4 2000

Bibliographical note

Funding Information:
Supported by American Foundation for Pharmaceutical Education Fellowships (AKB and DRW) and National Institute of Alcohol Abuse and Alcoholism Grant #AA12600. The authors also acknowledge the NIH Anticonvulsant Drug Development program (Epilepsy Branch, National Institute of Neurological Disorders and Stroke) for their role in the neurotoxicity assessment.

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Aminoanthraquinones as novel ligands at the polyamine binding site on the N-methyl-D-aspartate receptor complex'. Together they form a unique fingerprint.

Cite this